Cargando…
Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
OBJECTIVES: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for C...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067553/ https://www.ncbi.nlm.nih.gov/pubmed/37020473 http://dx.doi.org/10.1515/pp-2022-0133 |
_version_ | 1785018496758841344 |
---|---|
author | Charleux-Muller, Diane Fabacher, Thibaut Romain, Benoit Meyer, Nicolas Brigand, Cécile Delhorme, Jean-Baptiste |
author_facet | Charleux-Muller, Diane Fabacher, Thibaut Romain, Benoit Meyer, Nicolas Brigand, Cécile Delhorme, Jean-Baptiste |
author_sort | Charleux-Muller, Diane |
collection | PubMed |
description | OBJECTIVES: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for CCRS and HIPEC in a referral center. METHODS: We conducted a study with a prospective group of 44 patients (post-ERP group) who underwent CCRS with HIPEC between July 2016 and June 2018, the period during which ERP was implemented. This group was compared to a second retrospective group of 21 patients who underwent CCRS with HIPEC between June 2015 and June 2016, during which ERP was not yet implemented (pre-ERP group). RESULTS: The ERP compliance rate was 65% in the post-ERP group. The hospital length of stay (HLS) was shorter in the post-ERP group: 24.9 days (IQR 11–68, pre-ERP group) vs. 16.1 days (IQR 6–45, post-ERP group), as was the major morbidity rate (pre-ERP group=33.3% vs. post-ERP group=20.5%). The nasogastric tube, urinary catheter and abdominal drains were all retrieved faster in the post-ERP group. CONCLUSIONS: The implementation of an adapted ERP after CCRS with HIPEC procedures reduces morbidity and shortens the HLS. |
format | Online Article Text |
id | pubmed-10067553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-100675532023-04-04 Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study Charleux-Muller, Diane Fabacher, Thibaut Romain, Benoit Meyer, Nicolas Brigand, Cécile Delhorme, Jean-Baptiste Pleura Peritoneum Article OBJECTIVES: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for CCRS and HIPEC in a referral center. METHODS: We conducted a study with a prospective group of 44 patients (post-ERP group) who underwent CCRS with HIPEC between July 2016 and June 2018, the period during which ERP was implemented. This group was compared to a second retrospective group of 21 patients who underwent CCRS with HIPEC between June 2015 and June 2016, during which ERP was not yet implemented (pre-ERP group). RESULTS: The ERP compliance rate was 65% in the post-ERP group. The hospital length of stay (HLS) was shorter in the post-ERP group: 24.9 days (IQR 11–68, pre-ERP group) vs. 16.1 days (IQR 6–45, post-ERP group), as was the major morbidity rate (pre-ERP group=33.3% vs. post-ERP group=20.5%). The nasogastric tube, urinary catheter and abdominal drains were all retrieved faster in the post-ERP group. CONCLUSIONS: The implementation of an adapted ERP after CCRS with HIPEC procedures reduces morbidity and shortens the HLS. De Gruyter 2023-01-11 /pmc/articles/PMC10067553/ /pubmed/37020473 http://dx.doi.org/10.1515/pp-2022-0133 Text en © 2022 the author(s), published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. |
spellingShingle | Article Charleux-Muller, Diane Fabacher, Thibaut Romain, Benoit Meyer, Nicolas Brigand, Cécile Delhorme, Jean-Baptiste Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study |
title | Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study |
title_full | Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study |
title_fullStr | Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study |
title_full_unstemmed | Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study |
title_short | Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study |
title_sort | implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067553/ https://www.ncbi.nlm.nih.gov/pubmed/37020473 http://dx.doi.org/10.1515/pp-2022-0133 |
work_keys_str_mv | AT charleuxmullerdiane implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy AT fabacherthibaut implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy AT romainbenoit implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy AT meyernicolas implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy AT brigandcecile implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy AT delhormejeanbaptiste implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy |